Free Trial

BioRestorative Therapies Q4 2022 Earnings Report

BioRestorative Therapies logo
$1.80 -0.16 (-8.16%)
As of 02/21/2025 04:00 PM Eastern

BioRestorative Therapies EPS Results

Actual EPS
-$1.18
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioRestorative Therapies Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioRestorative Therapies Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

BioRestorative Therapies Earnings Headlines

BioRestorative Therapies- BRTX-100 program receives FDA Fast Track designation
BRTX-100 Front and Center at ORS 2025
The FED is losing the war on inflation
It's no longer just a “guesstimate” – Inflation is indeed getting worse. And although we want to believe the Fed has a good grip on it, they don't. Right now, the suits over there are caught between a rock and a hard place. Either they watch as inflation grows, or they tear it down and send us into a full-blown recession. The kicker here is that neither of these are good for you. Whichever pill we end up with, prices will still climb higher as the value of the dollar sinks lower. The only real way out for the regular person is to increase your earning power. By increasing your income to match prices as they flare up… You’ll stay ahead of the impending doom we're running face-first into. And if you're looking for a strategy to help increase your income in 2025… I've got just the thing for you! You see, last year, I was able to grow a $10k model account to a little over $63k with 100 trade alerts But I changed my trading rules and more than doubled my results on those 100 published trades. I'm now calling them Warped Options…
Roth MKM Remains a Buy on BioRestorative Therapies (BRTX)
See More BioRestorative Therapies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioRestorative Therapies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioRestorative Therapies and other key companies, straight to your email.

About BioRestorative Therapies

BioRestorative Therapies (OTCMKTS:BRTX) engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.

View BioRestorative Therapies Profile

More Earnings Resources from MarketBeat